Transplant Energize Me Patient Outcome (TEMPO): A Quality Improvement Project that Maintains Functional Mobility in Pediatric Patients Admitted for Allogeneic Hematopoietic Cell Transplantation.


Journal

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628

Informations de publication

Date de publication:
09 2019
Historique:
received: 22 02 2019
revised: 17 04 2019
accepted: 05 05 2019
pubmed: 16 5 2019
medline: 30 7 2020
entrez: 16 5 2019
Statut: ppublish

Résumé

Allogeneic hematopoietic cell transplantation (HCT) remains the definite cure for many pediatric hematologic diseases but causes profound deconditioning, which impairs daily physical functioning and may lead to further health complications. The Transplant Energize Me Patient Outcome (TEMPO) project is a standard-of-care, quality improvement (QI) project whose primary objective is to maintain physical functional mobility and strength throughout admission for pediatric allogeneic HCT patients. Specifically, TEMPO incorporates individualized and developmentally appropriate exercises and activities that are administered by a multidisciplinary team, who objectively measure and record a patient's physical stamina at predetermined frequencies. Discipline-specific metrics at admission, at weekly intervals, at discharge, and at 100 days after graft infusion (D100) are recorded in templated flowsheets in the electronic medical record. As a secondary objective, resource utilization as measured by length of stay, duration of parenteral feeds and narcotics, readmission by D100, and infections was compared between TEMPO and historical control (pre-TEMPO) allogeneic HCT patients. TEMPO participation maintained physical endurance and functional strength throughout hospitalization, an effect that was significantly sustained or improved at D100. Resource utilization did not significantly differ between patient cohorts. Taken together, the TEMPO QI Project maintains physical functional mobility, strength, and endurance, thereby decreasing physical deconditioning in pediatric allogeneic HCT patients, an effect that is objectively sustained at D100.

Identifiants

pubmed: 31085304
pii: S1083-8791(19)30288-5
doi: 10.1016/j.bbmt.2019.05.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1779-1785

Informations de copyright

Copyright © 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Auteurs

Anne Gonzales (A)

Clinical Therapy Services, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: anne.gonzales@nationwidechildrens.org.

Erin Gates (E)

Clinical Therapy Services, Nationwide Children's Hospital, Columbus, Ohio.

Nabanita Bhunia (N)

Hematology/Oncology/Blood and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio.

Lubna Mehyar (L)

Hematology/Oncology/Blood and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio.

Hasan Hashem (H)

Hematology/Oncology/Blood and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio.

Joseph R Stanek (JR)

Hematology/Oncology/Blood and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio.

Bonnie Krebs (B)

Hematology/Oncology/Blood and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio.

Jeffery J Auletta (JJ)

Hematology/Oncology/Blood and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio; Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio; Host Defense Program, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, Ohio; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH